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Albumin is the major plasma protein target of oxidant stress is manifested by an increase in plasma protein oxidation,
in uremia. including thiol group oxidation, and protein carbonyl
Background. Patients with uremia are exposed to increased formation [3]. We have also demonstrated that plasmaoxidative stress. Examination of the oxidation of individual
proteins from patients on chronic dialysis contain 3-chlo-plasma proteins may be useful in establishing specific pathways
rotyrosine, a biomarker for myeloperoxidase catalyzedof oxidative stress in vivo and in determining functional conse-
quences of oxidant stress exposure. We therefore examined oxi- oxidative reactions [4]. Miyata et al have used the term
dative modification of plasma proteins by carbonyl formation “carbonyl stress” to describe the excess oxidative forma-
using Western blot immunoassay and enzyme-linked immuno- tion of carbonyl groups (aldehydes and ketones) detect-sorbent assay (ELISA) techniques in patients with chronic
able in proteins, lipids, and carbohydrates in patientsrenal failure (CRF) and on chronic hemodialysis therapy (HD).
with chronic renal failure (CRF) [5]. Carbonyl formationMethods. Plasma was obtained from 25 HD, 20 CRF, and
20 healthy volunteers, derivatized with 2,4 dinitrophenylhy- may be important in the development of 2-microglobu-
drazine (DNP) and electrophoresed on duplicate 4 to 12% lin amyloidosis and accelerated atherosclerosis in pa-
gradient sodium dodecyl sulfate-polyacrylamide gel electro-
tients with renal failure [5–7].phoresis (SDS-PAGE) gels, transferred to nitrocellulose, and
To date, investigations of plasma protein oxidation instained for DNP for carbonyls and amido black for protein
content. Data are recorded as DNP area/protein area and are patients with CRF have utilized methods that measure
reported in densitometry units. Total plasma carbonyls were cumulative oxidation and do not assess oxidation of indi-
determined by ELISA. vidual plasma proteins. Examination of individual plasma
Results. Plasma albumin is substantially more oxidized in
proteins may be useful in establishing specific pathwaysHD than in healthy volunteers (1.22 0.14 densitometry units
of oxidative stress in vivo and in determining the poten-vs. 0.60 0.08, P 0.002). There were no significant differences
in oxidation of plasma transferrin, immunoglobulin, and fi- tial functional consequences of oxidant stress exposure
brinogen in HD versus healthy volunteers. In CRF patients, [1]. Recently, Shacter et al developed a Western blot
plasma albumin is more oxidized compared with normal volun- immunoassay that takes advantage of the ability to deriv-teers (1.36 0.20 densitometry units vs. 0.94 0.08, P 0.09).
atize carbonyl groups with 2,4 dinitrophenylhydrazineThere were no differences in oxidation of plasma transferrin,
(DNP) [8, 9]. Derivatized proteins can then be detectedfibrinogen, and immunoglobulin in CRF patients versus healthy
volunteers. An increased plasma protein carbonyl concentra- by sodium dodecyl sulfate-polyacrylamide gel electro-
tion in CRF patients compared with healthy volunteers was phoresis (SDS-PAGE) and immunoassay with anti-DNP
confirmed by ELISA (0.31  0.07 vs. 0.04  0.01 nmol/mg antibodies, thus providing a highly sensitive techniqueprotein (P  0.001).
for detecting oxidation of individual proteins. Using thisConclusion. Albumin is the major plasma protein target of
immunoassay technique, we have demonstrated that oxi-oxidant stress in CRF and HD patients.
dation of albumin accounts for almost all of the excess
plasma protein oxidation in patients with uremia.
Proteins are among the main targets of oxidation in
the plasma [1, 2]. We have previously demonstrated that
METHODSoxidative stress in patients on chronic hemodialysis (HD)
Patient characteristics
Twenty-five patients were on chronic maintenanceKey words: carbonyl stress, plasma protein oxidation, chronic renal
failure, hemodialysis, dialysis, Western blot, ELISA. HD. Twenty patients with CRF did not receive renal
replacement therapy, and 20 healthy volunteers were stud-Received for publication July 31, 2000
ied. Blood was drawn into vacutainer tubes containingand in revised form February 7, 2001
Accepted for publication February 19, 2001 ethylenediaminetetraacetic acid (EDTA) supplemented
with 1000 U/mL catalase and centrifuged at 1700 g for 2001 by the International Society of Nephrology
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Table 1. Characteristics of the patient groups the same size section of the blot in each scan. The analysis
box included 14 lanes for each analysis. The uniformNormal CRF HD
window size and analysis box ensured that data wereAge 624 624 72.62.0
Sex M/F 17/3 17/3 13/12 being analyzed consistently from band to band and from
Diabetes 8/20 8/20 10/25 blot to blot. Because the concentration of various plasma
Albumin g/dL 3.80.1 3.40.1
proteins differs between patient groups and healthy vol-Total protein g/dL 6.70.2 6.00.1
Cholesterol mg/dL 19111 1515.5 unteers, densitometry data for the area of the DNP blot
Creatinine mg/dL 4.30.3 7.80.5 band were divided by the densitometry data for the area
BUN mg/dL 634 593.8
of the protein blot band obtained under identical gelURR 723
loading and electrotransfer conditions. These data areAbbreviations are: BUN, blood urea nitrogen; CRF, chronic renal failure;
HD, hemodialysis; URR, urea reduction ratio. recorded as DNP area/protein area and are reported in
densitometry units. The mean was calculated for each
subject group on each blot.
15 minutes. For CRF patients, the mean serum creatinine Total plasma protein carbonyl measurement
was 4.3  0.3 mg/dL, and creatinine clearance was 23.5 Plasma protein carbonyl concentration was determined
2.1 mL/min. All HD patients were routinely receiving by enzyme-linked immunosorbent assay (ELISA) using
treatment with high-flux polysulfone membranes and a the Zentech PC Test Kit (Zenith Technology, Dunedin,
bicarbonate-based dialysate with heparinization. For New Zealand).
HD patients, blood was drawn predialysis. Informed con-
sent was obtained from all subjects, and the protocol Statistics
was approved by the Institutional Review Board. Table Data were analyzed using analysis of variance
1 displays the characteristics of the patient groups. (ANOVA) and the Student t test comparing the means
of patients versus controls on each blot. Results are re-Western blotting technique
ported as mean  SEM.
Oxidation of individual plasma proteins was measured
by analysis of Western blots according to the method of
RESULTSShacter et al [8]. Total protein was determined by the
Bio-Rad Protein Assay (Bio-Rad Laboratories, Her- Figure 1 shows representative Western blots using
cules, CA, USA). Plasma was diluted to 2 mg/mL with anti-DNP antibodies to measure carbonyl formation and
phosphate-buffered saline (PBS) and derivatized with amido black for analysis of protein concentration, re-
DNP using the OxyBlot Kit (Oncor, Gaithersburg, MD, spectively. It can readily be appreciated that there is
USA). Samples were diluted to 1 mg/mL by the addition considerably more carbonyl detected in chronic hemodi-
of an equal volume of 2  nonreducing sample buffer, alysis patients (lanes 1 through 4, 6, and 7) as compared
and 15 L samples were electrophoresed according to with healthy volunteers (lanes 5 and 8) in Figure 1A.
the method of Laemmli on duplicate 4 to 12% gradient Figure 2 summarizes the extent of plasma protein car-
SDS-PAGE gels (Novex, San Diego, CA, USA) for 90 bonyl formation in chronic hemodialysis patients com-
minutes at 125 V. Following overnight electroblotting to pared with healthy volunteers for the major plasma pro-
nitrocellulose at 30 V, one blot was stained for DNP teins. In chronic hemodialysis patients, plasma albumin
using OxyBlot Kit reagents. Bands were visualized with is substantially more oxidized than albumin in healthy
chemiluminescent chemicals and captured on film at four volunteers (1.22  0.14 densitometry units vs. 0.60 
exposure times (15 sec, 1 min, 5 min, and 10 min). The 0.08, P  0.002). In contrast, there are no significant
second blot was stained with amido black for protein. differences in the extent of oxidation of plasma trans-
Blots were scanned on an StudioStar scanner (Agfa Cor- ferrin (1.43  0.34 vs. 1.21  0.18 densitometry units,
poration, Ridgefield Park, NJ, USA) and analyzed for P  0.59), immunoglobulin (1.48  0.08 vs. 1.29  0.11
band area using NIH Image software. densitometry units, P 0.19), and fibrinogen (1.46 0.34
vs. 1.6  0.59 densitometry units, P  0.84) in chronic
Analysis of blots hemodialysis patients versus healthy volunteers, al-
though there was a trend toward increased immunoglob-Each Western blot included both patient and healthy
volunteer samples so that in all experiments, patient ulin oxidation versus healthy volunteers. These results
demonstrate that oxidation of albumin accounts for vir-samples were compared with healthy volunteers devel-
oped under the same conditions. For each experiment, tually all of the increased plasma protein carbonyl forma-
tion found in chronic hemodialysis patients.carbonyl density was determined from the blot with the
shortest possible exposure time that produced clearly Figure 3 analyzes the extent of plasma protein car-
bonyl formation in patients with CRF compared withvisible bands. DNP and protein blots were scanned using
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Fig. 1. Western blots of plasma from healthy
volunteers (lanes 5 and 8) and chronic hemo-
dialysis patients (lanes 1 through 4, 6, 7) after
derivatization and staining with Oxyblot Kit
reagents using a 15-second film exposure (A)
or with amido black (B).
Fig. 2. Plasma protein carbonyl formation mea-
sured by Western blot chronic hemodialysis
patients (; N 25) versus healthy volunteers
(; N  6). *P  0.05 vs. healthy volunteers.
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Fig. 3. Plasma protein carbonyl formation mea-
sured by Western blot in CRF patients (; N
20) versus healthy volunteers (; N  20).
*P  0.09 vs. healthy volunteers.
Table 2. Comparison of two subject groups
with versus without diabetes
Healthy CRF
No diabetes Diabetes No diabetes Diabetes
Albumin 1.040.22 1.200.15 1.660.22 1.750.33
Transferrin 1.890.48 1.500.22 3.441.11 4.041.45
Immunoglobulin 0.860.26 0.850.12 1.290.18 1.290.29
Fibrinogen 2.110.59 1.180.10 2.230.30 2.820.85
Values are from 2 blots with matched sets of subjects, N  6 in each group.
Values are in densitometry units and expressed as mean  SEM.
Fig. 4. Plasma protein carbonyl formation measured by ELISA tech-
niques in age-, sex-, and diabetes-matched healthy volunteers (N  20
for healthy volunteers and N  20 for CRF patients, *P  0.001 vs.
healthy volunteers. Similar to chronic hemodialysis pa- healthy volunteers).
tients, in patients with CRF, plasma albumin is more
oxidized compared with healthy volunteers (1.36  0.20
densitometry units vs. 0.94  0.08), although of border-
prior to the initiation of renal replacement therapy, weline significance (P  0.09). In patients with CRF, as in
wished to examine whether there was a correlation be-patients on hemodialysis, the extent of plasma transferrin
tween the level of creatinine clearance and plasma pro-(2.09 0.90 vs. 1.41 0.21 densitometry units, P 0.48),
tein carbonyl formation in this patient population. West-immunoglobulin oxidation (1.15  0.18 vs. 0.89  0.12
ern blotting analysis allows only an accurate comparisondensitometry units, P  0.26), and fibrinogen (2.07 
of plasma protein carbonyl formation of plasma samples0.33 vs. 2.09  0.39 densitometry units, P  0.97) was
run on the same gel, and thus is less suitable for overallnot significantly different from healthy volunteers.
group correlations. Therefore, the total plasma proteinAs many patients with CRF have diabetes mellitus
carbonyl formation in patients with CRF were comparedand because diabetes mellitus has been associated with
with healthy volunteers using an ELISA technique. Pa-oxidative stress independent of the development of renal
tients with CRF (range of creatinine clearance 16 to 46failure, we compared plasma protein carbonyl formation
mL/min) had a significantly elevated total plasma proteinin our study group patients with CRF and healthy volun-
teers with and without diabetes mellitus (Table 2). For carbonyl concentration compared with healthy volun-
healthy volunteers with diabetes mellitus (N  6), there teers (0.31  0.07 nmol per mg protein in CRF patients
was no significant difference in oxidation of albumin vs. 0.04  0.01 nmol per mg protein healthy volunteers,
(1.20 0.15 densitometry units vs. 1.04 0.22, P 0.55), P  0.001; Fig. 4). Figure 5 illustrates that for the 20
transferrin (1.49  0.22 densitometry units vs. 1.89  patients with CRF, there was no significant relationship
0.48, P 0.48), immunoglobulin (0.85 0.12 densitome- between creatinine clearance and levels of plasma pro-
try units vs. 0.86  0.26, P  0.98), or fibrinogen (1.18  tein carbonyl concentration (R2  0.01).
0.10 densitometry units vs. 2.11  0.59, P  0.18) com-
pared with healthy volunteers without diabetes mellitus
DISCUSSION(N 6). In patients with CRF, there were also no signifi-
This study used Western blotting to demonstrate thatcant differences in oxidation of albumin, transferrin, im-
plasma albumin is the major plasma protein target ofmunoglobulin, or fibrinogen between patients with (N 
excess oxidant stress in CRF and chronic hemodialysis6) and without diabetes mellitus (N  6; Table 2).
Since oxidative stress increases in patients with CRF patients. To our knowledge, the present study is the first
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acid and other oxidants and are known to be largely
located on albumin [20, 21]. While ascorbate is an impor-
tant extracellular antioxidant, albumin, via its thiol groups,
provides quantitatively almost tenfold greater antioxi-
dant protection against hypochlorous acid in human
plasma [18]. The demonstration of albumin carbonyl for-
mation in this study, in conjunction with our previous
work demonstrating plasma protein thiol group oxida-
tion in patients with uremia [3], indicates that this patient
population is at considerable risk of tissue oxidant injury
because of decreased plasma antioxidant defense.
Another important finding in this study is that patients
Fig. 5. Relationship between creatinine clearance and total plasma with advanced CRF not receiving renal replacement
protein carbonyls measured by ELISA in 20 CRF patients (R2  0.01).
therapy already have evidence of exposure to increased
oxidative stress manifested by plasma protein carbonyl
formation. The predominance of albumin as the target
of protein oxidation in patients with CRF is similar toto use Western blotting techniques to detect differential
susceptibility of plasma proteins to carbonyl formation patients on chronic HD therapy, although of borderline
statistical significance. These data are in accordance within vivo in any pathophysiologic disease state.
Cardiovascular disease continues to be the major cause our study demonstrating that plasma protein thiol group
oxidation is also present in patients with CRF prior to theof both morbidity and mortality for patients on chronic
dialysis therapy. For chronic hemodialysis patients, the introduction of renal replacement therapy [3]. Recent
investigators have emphasized that both markers of in-annual mortality caused by cardiovascular causes is ap-
proximately 9%, which is 10- to 20-fold higher than the flammation and hypoalbuminemia frequently begin in
the pre-ESRD period [22]. Other investigators havegeneral population, even when adjusted for age, sex, race,
and the presence or absence of diabetes [10]. Additional pointed out the importance of the pre-ESRD period in
the generation of cardiovascular risk factors that contrib-risk factors for cardiovascular disease in the general pop-
ulation have been shown to have only modest predictive ute to the high cardiovascular mortality of patients on
renal replacement therapy [23]. To the extent that oxida-power in dialysis patients, suggesting the need for “non-
traditional” markers of cardiovascular risk in this patient tive stress is involved in the genesis of atherosclerotic
complications in uremia, the data in this study wouldpopulation [11]. A recent study has suggested that anti-
oxidant therapy may lessen cardiovascular complications suggest that the process begins substantially prior to the
initiation of renal replacement therapy.in end-stage renal disease (ESRD) patients, suggesting
that oxidant stress may be an important “nontraditional” Shacter et al have used an in vitro iron/ascorbate hy-
droxyl radical generating system to study plasma proteinfactor [12].
A potential link between inflammation, hypoalbumin- oxidation using the same Western blotting assay for car-
bonyl groups. Of interest, they were able to demonstrateemia, and subsequent cardiovascular risk may be through
the process of oxidative stress. Chronic inflammatory an increased susceptibility of fibrinogen to oxidative
modification compared with other proteins [8, 9]. Fibrin-stimuli result in phagocytic cell activation with subse-
quent increased production of reactive oxygen species. ogen contains a number of calcium-binding sites that
may also bind to iron; this may be the explanation forPhagocyte-derived oxidants are now believed to be cen-
tral to the mechanisms of atherosclerosis formation increased fibrinogen susceptibility to oxidation in a metal-
dependent oxidizing system. The lack of excess fibrino-[13, 14]. Since albumin is known to be an important
plasma antioxidant [15–18], the finding of a predisposi- gen carbonyl formation in chronic hemodialysis patients
or CRF patients compared with healthy volunteers intion of albumin to oxidation in renal failure also suggests
a mechanism by which hypoalbuminemia contributes to the present study suggests that metal-catalyzed oxidative
chemistry may not be as important in vivo as myelperoxi-the development of cardiovascular risk.
Plasma is known to contain a wide range of important dase-catalyzed reactions and other pathways in these
patients.antioxidants, including albumin, ascorbate, and urate. In
contrast, concentrations of superoxide dismutase, re- In summary, we have used Western blotting techniques
measuring carbonyl formation to demonstrate that albu-duced glutathione, and catalase, all of which are known
to be important intracellular antioxidants, are low in the min is the predominant oxidatively modified plasma pro-
tein in patients with CRF and patients on HD. Oxidationplasma and are not likely to be important plasma antioxi-
dants [16, 19]. In plasma, free thiol groups are quantita- of albumin will decrease plasma antioxidant defenses
and increase the likelihood of oxidant stress-induced tis-tively the most important scavengers of hypochlorous
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of fibrinogen and other plasma proteins. Arch Biochem Biophyssue injury and cardiovascular disease in this patient pop-
321:175–181, 1995
ulation. 10. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascu-
lar disease in chronic renal disease. J Am Soc Nephrol 9:S16–S23,
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